Related Experiment Video
Updated: Jun 8, 2026

A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
Published on: February 28, 2021
Autoimmune pancreatitis--a new evolving pancreatic disease?
Kazuichi Okazaki1, Kazushige Uchida, Toshiro Fukui
1The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Shinmachi, Hirakata, Osaka, 573-1197, Japan. okazaki@hirakata.kmu.ac.jp
Autoimmune pancreatitis (AIP) is a systemic disease. Its pathogenesis involves a biphasic mechanism with early induction by self-antigens and later progression influenced by regulatory T cells (Tregs) and immune responses.
Area of Science:
- Immunology
- Gastroenterology
- Pathology
Background:
- Autoimmune pancreatitis (AIP) is increasingly recognized as a systemic disease, evidenced by extrapancreatic lesions sharing pathological features with pancreatic lesions.
- These shared features include fibrosis, abundant IgG4-positive plasma cell infiltration, and responsiveness to steroid therapy, leading to proposed diagnostic criteria.
- Despite global acceptance as a distinct clinical entity, the precise pathogenetic mechanisms underlying AIP remain incompletely understood.
Purpose of the Study:
- To elucidate the pathogenetic mechanisms of autoimmune pancreatitis (AIP).
- To review and synthesize current knowledge on genetic, humoral, and cellular immunity aspects of AIP.
- To propose a biphasic model for AIP pathogenesis involving induction and progression phases.
Main Methods:
- Comprehensive review of existing literature on genetic background, humoral immunity, target antigens (self-antigens and microbial mimicry), cellular immunity (including regulatory T cells), complement system activation, and experimental models.
- Analysis of findings to formulate a hypothesis for AIP pathogenesis.
- Examination of the roles of regulatory T cells (Tregs) and immune responses in both disease induction and progression.
Main Results:
- A biphasic pathogenetic mechanism for AIP, termed "induction" and "progression," is proposed.
- The induction phase involves an initial response to self-antigens or molecular mimicry (e.g., Helicobacter pylori), triggered by decreased naive regulatory T cells (Tregs).
- This early phase is characterized by Th1 cell-mediated release of pro-inflammatory cytokines (IFN-γ, IL-1b, IL-2, TNF-α).
Conclusions:
- The progression phase in chronic AIP is characterized by increased memory Tregs and Th2 immune responses.
- Activation of the classical complement pathway may occur via IgG1 immune complexes.
- Regulatory T cells (Tregs) play critical roles in both the induction and progression of autoimmune pancreatitis, necessitating further research into their precise functions.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology

